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AXIAL-CENTRIFUGAL FLOW CATHETER 
PUMP FOR CAVOPULMONARY ASSISTANCE 
TECHNICAL FIELD 
The present invention relates generally to the ?eld of medi 
cal devices. In particular, the invention relates to cardiac 
medical devices and systems for use in remediating or alle 
viating failing circulation subsequent to a Fontan procedure. 
BACKGROUND OF THE INVENTION 
The Fontan or Fontan/Kreutzer procedure is a palliative 
(not curative) surgical procedure used to ameliorate complex 
congenital heart defects, especially in the young. Exemplary 
heart defects addressed by the Fontan procedure include heart 
valve defects (tricuspid atresia, pulmonary atresia), abnor 
malities in pumping ability of the heart (hypoplastic left heart 
syndrome, hypoplastic right heart syndrome), and other com 
plex congenital heart diseases where a bi-ventricular repair is 
not possible or contra-indicated (double inlet left ventricle, 
hetertaxy defects, double outlet right ventricle, etc.). The 
process was initially described as a surgical treatment for 
tricuspid atresia. 
As a result of the Fontan procedure, a surgically created 
junction is provided between the superior and inferior vena 
cava and the pulmonary artery, and venous blood ?ow is 
diverted from the superior and inferior vena cava directly to 
the pulmonary artery, bypassing the right ventricle of the 
heart. Following the procedure, oxygen-poor blood from the 
upper and lower body ?ows through the lungs without being 
pumped by the heart. Rather, the blood ?ow into the lungs is 
driven only by central venous blood pressure. This corrects 
hypoxia, and leaves a single heart ventricle responsible only 
for supplying blood to the body. 
However, disadvantages and post-surgical complications 
are associated with the Fontan procedure. In the short term, 
pleural effusions (?uid build-up around the lungs) can occur, 
requiring additional surgical interventions. In the long term, 
atrial scarring may be associated with atrial ?utter and atrial 
?brillation, also requiring additional surgical intervention. 
Other long-term risks may be associated with the procedure, 
such as protein-losing enteropathy and chronic renal insu?i 
ciency, although these latter risks are not yet fully quanti?ed. 
Also, a high central venous pressure is required to provide 
a satisfactory supply of blood to the lungs after the Fontan 
procedure. Immediately or even 2-5 years following the pro 
cedure, it is known that the surgically created Fontan circu 
lation often fails due to that high venous pressure required to 
drive pulmonary circulation. Long term mortality following 
the Fontan procedure can be as high as 29.1%, characterized 
by catastrophic failure of circulation and death. The expected 
event-free survival rate following the Fontan procedure at 
one, ten, and twenty-?ve years following the procedure is 
80.1%, 74.8%, and 53.6%, respectively. A bi-modal age dis 
tribution has been observed in failing Fontan circulation. In 
early post-operative cases of failing Fontan circulation, the 
Fontan connection must be surgically taken down. In later 
post-operative cases, often the only remedy is heart transplan 
tation. 
Because of the above complications, in cases of failing 
Fontan circulation cavopulmonary assistance is often indi 
cated, to actively move blood from the superior/inferior vena 
cava into pulmonary circulation, to decrease the central 
venous pressure required to provide the needed ?ow of blood 
to the lungs, and to reverse the pathophysiology associated 
with failing Fontan circulation. Attempts have been made to 
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alleviate failing Fontan circulation by implanting a right ven 
tricular assist device (RVAD). However, this requires a trau 
matic surgical intervention to implate the device, and also 
requires take-down of the Fontan connection to allow pump 
installation. Dual hemopumps have been evaluated to restore 
or assist failing Fontan circulation. However, in such cases 
using two hemopumps, two surgical site cannulations are 
required, which is unduly traumatic to a patient. Also, patient 
mobility is severely restricted when two pumps must be 
deployed by cannulation. 
A number of smaller pumps have been evaluated, but most 
require two pumping mechanisms for deployment in the 
superior and inferior vena cava (above and below the surgi 
cally created Fontan connection) to move blood toward and 
into pulmonary circulation. Because of the dual pumps/dual 
cannulations required, such pumps cannot be made ambula 
tory, i.e. the patient must be substantially bedridden after 
deployment of the pumps. Single pump mechanisms have 
been evaluated. Such pumps can create the required ?ow of 
blood into the pulmonary artery, but are di?icult to deploy and 
consistently maintain in position due to the need for precise 
placement at the Fontan anastomosis surgically created at the 
juncture of the superior/ inferior vena cava and the pulmonary 
artery. Proper alignment of this type of pump at the pulmo 
nary artery and retaining that proper alignment is di?icult to 
impossible, even with patient sedation, and further because of 
the di?iculting in maintaining proper positioning after 
deployment, such pumps cannot be made ambulatory. Still 
other single pump mechanisms considered require surgical 
creation of an offset between the superior and inferior vena 
cava to promote blood ?ow into the pulmonary artery, 
increasing surgical di?iculty and resultant complications for 
the patient. 
There is accordingly a need in the art for improvements to 
pumps for cavopulmonary assistance in the event of failing 
Fontan circulation. Such improved pumps should require 
only a single pump mechanism requiring only one cannula 
tion, but should still create satisfactory blood ?ow from both 
the superior and inferior vena cava into the pulmonary artery. 
Moreover, the pump should be relatively simple to deploy at 
the surgically created Fontan connection site, should not 
require absolutely precise placement to provide proper pump 
operation and blood ?ow, and should allow for a degree of 
displacement after deployment without affecting proper 
pump operation and blood ?ow. Still more, the pump should 
be ambulatory, allowing patient mobility and improved com 
fort after the procedure. 
SUMMARY OF THE INVENTION 
In accordance with the above-identi?ed need in the art, in 
one aspect the present disclosure provides an axial-centrifu 
gal ?ow catheter pump for cavopulmonary assistance, includ 
ing a rotor having elements providing both an axial ?uid ?ow 
and a centrifugal ?uid ?ow and a motor operatively connected 
to the rotor. The rotor includes a ?rst terminal impeller con 
?gured to provide a centrifugal and axial ?uid ?ow in a ?rst 
direction, a second terminal impeller con?gured to provide a 
centrifugal and axial ?uid ?ow in a second direction opposite 
to the ?rst direction, and a central impeller con?gured to 
provide a predominantly centrifugal ?uid ?ow. To provide the 
desired ?uid ?ow patterns, the ?rst and second terminal 
impellers each include blade arrangements con?gured to pro 
vide a centrifugal and axial ?uid ?ow directed toward the 
rotor central impeller. The ?rst and second terminal impeller 
blade arrangements may transition over the longitudinal axis 
of the rotor to de?ne the central impeller blade arrangement, 
US 8,777,832 B1 
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or alternatively the ?rst and second terminal impeller blade 
arrangements and the central blade arrangement may be sepa 
rate. 
In another aspect, a rotor as described above is provided for 
a two-stage axial-centrifugal ?ow catheter pump for cavop 
ulmonary assistance. 
In yet another aspect, a cavopulmonary assistance device is 
provided including an axial axial-centrifugal ?ow catheter 
pump as described above. The device includes a motor opera 
tively connected to the rotor, a cable connected to the rotor 
and/or the motor, and a deployable anchor for securing the 
cavopulmonary assistance device to a blood vessel wall. The 
motor may be directly connected to the rotor, or may be 
remotely operatively connected to the rotor such as via the 
cable. The deployable anchor is con?gured to allow ?uid ?ow 
therethrough when deployed. A protective enclosure allow 
ing ?uid ?ow therethrough surrounds at least the rotor to 
prevent damage to a blood vessel wall. 
These and other embodiments, aspects, advantages, and 
features of the present invention will be set forth in the 
description which follows, and in part will become apparent 
to those of ordinary skill in the art by reference to the follow 
ing description of the invention and referenced drawings or by 
practice of the invention. The aspects, advantages, and fea 
tures of the invention are realized and attained by means of the 
instrumentalities, procedures, and combinations particularly 
pointed out in the appended claims. Various patent and non 
patent citations are discussed herein. Unless otherwise indi 
cated, any such citations are speci?cally incorporated by ref 
erence in their entirety into the present disclosure. 
BRIEF DESCRIPTION OF THE DRAWINGS 
The accompanying drawings incorporated in and forming 
a part of the speci?cation, illustrate several aspects of the 
present invention, and together with the description serve to 
explain the principles of the invention. In the drawings: 
FIG. 1 depicts a normal human heart; 
FIG. 2 depicts the heart of FIG. 1 after completion of a 
Fontan procedure, showing the Fontan anastomosis placing 
the superior and inferior vena cava in ?uid communication 
with the pulmonary artery; 
FIG. 3 depicts an embodiment of a rotor for an axial 
centrifugal ?ow pump; 
FIGS. 4a, 4b, and 4c depict alternative embodiments of 
blade con?gurations for the impellers of the rotor of FIG. 3; 
FIGS. 5a and 5b depict embodiments of axial-centrifugal 
?ow pumps according to the present disclosure; and 
FIGS. 6a and 6b depict placement of the axial-centrifugal 
?ow pump of FIG. 5 at a site of a Fontan anastomosis, with 
FIG. 6a showing the device with an undeployed anchor and 
FIG. 6b showing the device with a deployed anchor to secure 
the device to the wall of the inferior vena cava. 
DETAILED DESCRIPTION OF THE 
ILLUSTRATED EMBODIMENTS 
In the following detailed description of the illustrated 
embodiments, reference is made to the accompanying draw 
ings that form a part hereof, and in which is shown by way of 
illustration, speci?c embodiments in which the invention may 
be practiced. These embodiments are described in su?icient 
detail to enable those skilled in the art to practice the inven 
tion. Also, it is to be understood that other embodiments may 
be utilized and that process, reagent, software, and/or other 
changes may be made without departing from the scope of the 
present invention. 
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In the normal heart (see FIG. 1), there is no direct ?uid 
communication between the superior vena cava (SVC), infe 
rior vena cava (IVC), and the pulmonary artery (PA). As is 
known in the art and as summarized above, in the Fontan 
procedure venous blood ?ow is diverted from the SVC and 
IVC directly to the PA, bypassing the right ventricle of the 
heart. By the procedure, a surgically created junction (Fontan 
anastomosis F) is provided between the superior and inferior 
vena cava and the pulmonary artery to allow ?uid communi 
cation between the vessels and directly into pulmonary cir 
culation (see FIG. 2). As summarized above, this Fontan 
circulation is prone to failure, requiring additional interven 
tion to reverse or ameliorate failing Fontan circulation and 
associated pathologies. 
In one aspect, the present disclosure provides a rotor 10 
(see FIG. 3) for an axial-centrifugal ?ow pump. The rotor 10 
includes ?rst and second terminal impellers 12, 14 and an 
elongated central shaft 16 supporting a central impeller 18. 
The ?rst and second impellers 12, 14 are each con?gured to 
create a centrifugal and axial ?uid ?ow when rotor 10 is 
rotated, speci?cally wherein the ?rst and second impellers 12, 
14 create axial ?uid ?ows in opposed directions (see arrows 
A). In particular embodiments, the ?rst and second impellers 
12, 14 include at least one blade 20 disposed at an included 
angle of from about 10 to about 30 degrees relative to a 
longitudinal axis of the rotor 10 to provide the desired axial 
and centrifugal ?uid ?ow. 
The central impeller 18, on the other hand, includes at least 
one blade 22 disposed whereby rotation of rotor 10 creates a 
predominantly centrifugal ?uid ?ow around central impeller 
16 (see arrows B). In particular embodiments, the central 
impeller 18 includes at least one blade 22 disposed at an 
included angle of from about 80 to about 100 degrees relative 
to a longitudinal axis of the rotor 10 to provide the desired 
centrifugal ?uid ?ow. In use, rotation of the rotor 10 will 
cause ?rst and second impellers 12, 14 to promote a centrifu 
gal and axial ?ow of ?uid in the direction of central impeller 
18, while central impeller 18 redirects that axial ?uid ?ow 
into a primarily centrifugal ?uid ?ow. 
In the embodiment shown in FIG. 3, the blades 20, 22 are 
of the Archimedean screw type. In the depicted embodiment 
of FIG. 3, blades 20 of the ?rst and second impellers 12, 14 
transition over a longitudinal axis of the rotor 10 to de?ne the 
blades 22 of the central impeller 18. However, a variety of 
blade con?gurations are contemplated for inclusion in the 
rotor 10 described above. As a non-limiting example, a pro 
peller or screw type blade 20 is contemplated for use in ?rst 
and second impellers 12, 14 (see FIG. 4a). Alternatively, ?rst 
and second impellers 12, 14 may include a plurality of dis 
crete blades 20 (see FIG. 4b); with the caveat that the blades 
20 must be oriented such that a centrifugal and axial ?uid ?ow 
is promoted as described above. As another alternative, an 
auger-type blade 20 may be used (see FIG. 40). Similar 
arrangements are contemplated for use as blades 22 of central 
impeller 18, with the caveat that the blades 22 must be ori 
ented such that a predominantly centrifugal ?uid ?ow is pro 
moted by the central impeller 18 as described above. 
In another aspect (see FIG. 5a), the present disclosure 
provides an axial-centrifugal ?ow pump 24 incorporating the 
rotor 10 as described above, for use as a cavopulmonary 
assistance device (CPAD). The rotor 10 is provided with 
bearing arrangements 26, 28 at opposed ends thereof to allow 
rotation of rotor 10. A number of bearings are contemplated 
for use as bearings 26, 28, including without intending any 
limitation ball bearings, roller bearings, cone bearings, ball 
thrust bearings, roller thrust bearings, magnetic bearings, and 
the like. 
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A motor 30 is operatively connected to rotor 10 to drive 
rotation thereof. In the embodiment of FIG. 5, the rotor 10 is 
held by bearings 26 in a micro motor 30. A stator 32 is 
provided at the opposed end of rotor 10, to support rotation of 
rotor 10 in conjunction with bearing 28. In an embodiment, 
bearing 28 may be a cone bearing of substantially known 
design, supported by stator 32. However, other designs are 
contemplated for bearings 26, 28 as described above. A pro 
tective enclosure 34 is also provided, to prevent contact of the 
rotor 10 with, e.g., a blood vessel wall interior. A number of 
suitable enclosures 34 are contemplated, such as a cage made 
of wire or other suitable materials allowing blood ?ow there 
through to prevent ?uid ?ow occlusion or reduction and areas 
of stagnant blood ?ow. Such devices are known in the art. An 
expandable or deployable anchor 36 is included at a terminus 
of the pump 24, whose function will be described in detail 
below. A cable 36 is provided at a terminus of the pump 24, 
one function of which is to facilitate placement of the pump 
34 at a desired location in a blood vessel. In combination, 
cable 36 and pump 24 de?ne a catheter pump which provides 
both an axial and a centrifugal ?uid ?ow as described above, 
in a compact, self-contained design promoting patient mobil 
ity after placement of the pump 24. 
The skilled artisan will appreciate that alternative con?gu 
rations are possible and are contemplated herein. For 
example, rather than directly associating the motor 30 with 
the pump 24 as depicted in the embodiment of FIG. 5, the 
motor 30 may be disposed remotely from the pump 24, and 
operatively connected to the rotor 10 via cable 36 (see FIG. 
5b). A second stator 32 and bearing 26 arrangement may be 
included to stabilize the end of rotor 10 connected to cable 36. 
In this embodiment, motor 30 may be positioned extracorpo 
really during use of pump 24, facilitating maintenance and/or 
replacement thereof in case of failure. 
Deployment and use of pump 24 such as in the event of 
failing Fontan circulation will now be described. As summa 
rized above, the Fontan procedure results in a surgically cre 
ated junction (Fontan anastomosis) between the superior and 
inferior vena cava and the pulmonary artery to allow ?uid 
communication between the vessels (see FIG. 2). To improve 
that failing Fontan circulation, pump 24 is inserted into, for 
example, the right jugular vein and therefrom into the supe 
rior vena cava and advanced using cable 36 and/ or a suitable 
guidewire/deployment catheter or balloon dilation catheter 
arrangement (not shown) of known design. Advancement and 
proper placement of pump 24 may be monitored by any 
suitable imaging technology, such as X-ray ?uoroscopy, radi 
ography, intravascular ultrasound, etc., to ensure proper posi 
tioning of the pump 24. 
The pump 24 is advanced until the rotor 10 bridges the 
Fontan anastomosis F (see FIG. 6a). As shown, ?rst impeller 
12 is positioned substantially in the superior vena cava 
(SVC), second impeller 14 is positioned substantially in the 
inferior vena cava (IVC), and central impeller 18 bridges the 
Fontan anastomosis F, i.e. the surgically created juncture 
between the SVC, IVC, right pulmonary artery (RPA), and 
left pulmonary artery (LPA). Once proper placement of the 
pump 24 is veri?ed, the expandable or deployable anchor 36 
is deployed to anchor the pump 24 to the IVC vessel wall and 
prevent undesired movement of the pump 24 (see FIG. 6b). 
Typically, an anchor 36 is used which allows ?uid ?ow there 
through after deployment, to prevent occlusion or reduction 
of blood ?ow through the blood vessel and to prevent areas of 
stagnant blood ?ow after the anchor 36 is deployed. 
On rotation of rotor 10, as described above ?rst and second 
impellers 12, 14 created a centrifugal and axial ?uid ?ow of 
blood in the direction of central impeller 18 (see arrows A). In 
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turn, as rotor 10 rotates, central impeller 18 creates a predomi 
nantly centrifugal ?uid ?ow of blood substantially at the 
location of the Fontan anastomosis, accelerating blood spin 
ning in this region of the superior and inferior vena cava and 
creating a high pressure zone in the region of the blood vessel 
extending between the ?rst and second impellers 12, 14 (see 
shaded area Z). This provides a delivery of blood at substan 
tially right angles into the RPA and LPA (arrows C). By the 
pump 24 of the present disclosure, blood ?ow is promoted 
from the superior vena cava/inferior vena cava into the pul 
monary circulation, eliminating the increased central venous 
pressure required to promote this type of blood ?ow as is 
typically associated with Fontan procedure. 
A number of advantages are realized by the rotor 10/axial 
centrifugal ?ow pump 24 design of the present disclosure. For 
example, separation of the ?rst and second impellers 12, 14 
by elongated shaft 16 allows for some movement of the rotor 
10/pump 24 within the superior vena cava and inferior vena 
cava after placement and deployment of anchor 36 without 
affecting the performance of pump 24 and without disrupting 
the blood ?ow created by pump 24 as described above. This 
eliminates the need for unduly precise placement at the site of 
a Fontan anastomosis associated with prior art pumps to 
promote the desired blood ?ow into pulmonary circulation, 
and also obviates the loss of performance of such prior art 
pumps if the pump is at all displaced during use. In turn, a 
compact, effective, and ef?cient pump 24 design is provided 
which, by its size and ?exibility in placement, allows patient 
ambulation after the pump 24 is placed. 
One of ordinary skill in the art will recognize that addi 
tional embodiments of the invention are also possible without 
departing from the teachings herein. This detailed descrip 
tion, and particularly the speci?c details of the exemplary 
embodiments, is given primarily for clarity of understanding, 
and no unnecessary limitations are to be imported, for modi 
?cations will become obvious to those skilled in the art upon 
reading this disclosure and may be made without departing 
from the spirit or scope of the invention. Relatively apparent 
modi?cations, of course, include combining the various fea 
tures of one or more ?gures or examples with the features of 
one or more of other ?gures or examples. 
What is claimed is: 
1. An axial-centrifugal ?ow catheter pump for cavopulmo 
nary assistance, comprising: 
a rotor providing both an axial ?uid ?ow and a centrifugal 
a motor operatively connected to the rotor; 
the rotor including a ?rst terminal impeller con?gured to 
provide a centrifugal and axial ?uid ?ow in a ?rst direc 
tion, a second terminal impeller con?gured to provide a 
centrifugal and axial ?uid ?ow in a second direction 
opposite to the ?rst direction, and a central impeller 
con?gured to provide a predominantly centrifugal ?uid 
?ow. 
2. The axial-centrifugal ?ow catheter pump of claim 1, 
wherein the ?rst and second terminal impellers each include 
blade arrangements con?gured to provide a centrifugal and 
axial ?uid ?ow directed toward the rotor central impeller. 
3. The axial-centrifugal ?ow catheter pump of claim 2, 
wherein the ?rst and second terminal impeller blade arrange 
ments include at least one blade oriented at an included angle 
of from 10 to 30 degrees relative to a longitudinal axis of the 
rotor. 
4. The axial-centrifugal ?ow catheter pump of claim 1, 
wherein the central impeller includes a blade arrangement 
having at least one blade oriented at an included angle of from 
80 to 100 degrees relative to a longitudinal axis of the rotor. 
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5. The axial-centrifugal ?ow catheter pump of claim 4, 
wherein the ?rst and second terminal impeller blade arrange 
ments transition over the longitudinal axis of the rotor to 
de?ne the central impeller blade arrangement. 
6. A rotor for a two-stage axial-centrifugal ?ow catheter 
pump for cavopulmonary assistance, comprising: 
a ?rst terminal impeller con?gured to provide a centrifugal 
and axial ?uid ?ow in a ?rst direction; 
a second terminal impeller con?gured to provide a cen 
trifugal and axial ?uid ?ow in a second direction oppo 
site to the ?rst direction; and 
a central impeller con?gured to provide a predominantly 
centrifugal ?uid ?ow. 
7. The rotor of claim 6, wherein the ?rst and second termi 
nal impellers each include blade arrangements con?gured to 
provide a centrifugal and axial ?uid ?ow directed toward the 
rotor central impeller. 
8. The rotor of claim 7, wherein the ?rst and second termi 
nal impeller blade arrangements include at least one blade 
oriented at an included angle of from 10 to 30 degrees relative 
to a longitudinal axis of the rotor. 
9. The rotor of claim 6, wherein the central impeller 
includes a blade arrangement con?gured to provide a pre 
dominantly centrifugal ?uid ?ow and having at least one 
blade oriented at an included angle of from 80 to 100 degrees 
relative to a longitudinal axis of the rotor. 
10. The rotor of claim 9, wherein the ?rst and second 
terminal impeller blade arrangements transition over the lon 
gitudinal axis of the rotor to de?ne the central impeller blade 
arrangement. 
11. A cavopulmonary assistance device, comprising: 
an axial-centri?lgal ?ow catheter pump comprising a rotor 
providing both an axial ?uid ?ow and a centrifugal ?uid 
?ow and a motor operatively connected to the rotor; 
a cable connected to the rotor and/ or the motor; and 
a deployable anchor for securing the cavopulmonary assis 
tance device to a blood vessel wall; 
the rotor including a ?rst terminal impeller con?gured to 
provide a centrifugal and axial ?uid ?ow in a ?rst direc 
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tion, a second terminal impeller con?gured to provide a 
centrifugal and axial ?uid ?ow in a second direction 
opposite to the ?rst direction, and a central impeller 
con?gured to provide a predominantly centrifugal ?uid 
?ow. 
12. The cavopulmonary assistance device of claim 11, 
wherein the ?rst and second terminal impellers each include 
blade arrangements con?gured to provide a centrifugal and 
axial ?uid ?ow directed toward the rotor central impeller. 
13. The cavopulmonary assistance device of claim 12, 
wherein the ?rst and second terminal impeller blade arrange 
ments include at least one blade oriented at an included angle 
of from 10 to 30 degrees relative to a longitudinal axis of the 
rotor. 
14. The cavopulmonary assistance device of claim 11, 
wherein the central impeller includes a blade arrangement 
having at least one blade oriented at an included angle of from 
80 to 100 degrees relative to a longitudinal axis of the rotor. 
15. The cavopulmonary assistance device of claim 14, 
wherein the ?rst and second terminal impeller blade arrange 
ments transition over the longitudinal axis of the rotor to 
de?ne the central impeller blade arrangement. 
16. The cavopulmonary assistance device of claim 11, 
wherein the motor is directly connected to the rotor. 
17. The cavopulmonary assistance device of claim 11, 
wherein the motor is remotely operatively connected to the 
rotor. 
18. The cavopulmonary assistance device of claim 11, 
wherein the deployable anchor is con?gured to allow passage 
of ?uid therethrough when deployed. 
19. The cavopulmonary assistance device of claim 11, 
further including a bearing arrangement disposed at opposed 
ends of the rotor and a stator disposed at an end of the rotor 
opposed to the motor. 
20. The cavopulmonary assistance device of claim 11, 
further including a protective enclosure surrounding at least 
the rotor, the protective enclosure being con?gured to allow 
?uid ?ow therethrough. 
* * * * * 
